Among them, the immune checkpoint CD40L binding to CD40 could increase the immunomodulatory ability of DCs, induce effector cell proliferation and enhance immunotoxicity to tumor cells, which further indicated that CDN2 and CDN4 had strong immune activation ability. This evidence concerns the gene CD40 and neoplasm.